Answers are grounded in this paper and cite their sources.
Objective To investigate the clinical significance of serum tumor markers carbohydrate antigen 125 (CA125), cytokeratin 21-1 fragment (CYFR21-1), nerve specific enolase (NSE), squamous cell antigen (SCC), carcinoembryonic antigen (CEA) and tumor related substances (TSGF) in the diagnosis of lung cancer. Methods Eighty patients with lung cancer [divided into three subunits according to the type of lung cancer; lung squamous cell carcinoma group, lung adenocarcinoma group and small cell lung cancer (SCLC)group], 54 patients with lung benign disease and 52 healthy controls were enrolled in this study. Immunofluorescence method was used to detect the expression of the above six tumor markers among the three groups, and their differences were compared. Results The levels of serum CA125, CYFR21-1, NSE, CEA, SCC and TSGF of patients with lung cancer were significantly higher than those of healthy controls (P 0.05). The sensitivity of the combined detection of the six serum tumor markers was significantly different from that of each single item (all P<0.01). Conclusions Combined detection of tumor markers in diagnosis of lung cancer and pathological typing is superior to the single detection, and has high clinical value.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: